NEW ZEALAND DATA SHEET - Medsafe

Madopar (levodopa) Data Sheet (DS) - Medsafe

MADOPAR 160202 1 Data Sheet MADOPAR® Levodopa + benserazide Capsules 62.5, 125 and 250; dispersible tablet 62.5; HBS modified-release capsule 125

  Levodopa, Dispersible

Section 1: Legislation - Medsafe Home Page

Section 2: Overview of Regulation of Clinical Trials in New Zealand . Section summary Under Section 30 of the Medicines Act 1981, approval from the Director-General of

  Section, Clinical, Legislation, Section 1

Section 1: Legislation relating to the labelling - …

Part 5, Ed 1.6 Page 2 of 18 . Section 1: Legislation relating to the labelling of medicines and related products Section summary This section lists the legislation regulating the labelling of medicines and related products.

  Section, Relating, Legislation, Labelling, Section 1, Legislation relating to the labelling

NEW ZEALAND DATA SHEET VERMOX® - …

NEW ZEALAND DATA SHEET VERMOX® Vermox® Page 2 of 7 For control of enterobiasis Adults and children 2-12 years: 1 Vermox tablet (100 mg) or 5 mL of suspension (100 mg) is given.

Guideline on the Regulation of Therapeutic …

Guideline on the Regulation of Therapeutic Products in New Zealand Part 10: Requirements for information for prescribers and consumers Edition 7.0

  Guidelines, Product, Regulations, Therapeutic, Guideline on the regulation of therapeutic, Guideline on the regulation of therapeutic products in

Clonazepam: oral drops (2.5 mg/ml); injection (1 mg).

2. you have severe and chronic lung disease 3. you have severe liver disease 4. you have an addiction to drugs or alcohol 5. the package is torn or shows signs of tampering

  Clonazepam

NEW ZEALAND DATA SHEET - Medsafe

NEW ZEALAND DATA SHEET 5 Hypnovel 170717 Medical history of alcohol or drug abuse Hypnovel should be avoided in patients with a medical history of alcohol or drug abuse.

  Drug

SCHEDULE OF FEES (effective from 1 July 2018)

Page 1 of 10. SCHEDULE OF FEES (effective from 1 July 2018) • All fees listed are GST inclusive. • More detailed descriptions of the type of application or change to which a fee applies can be

  Schedule, Effective, Fees, Schedule of fees

Nortriptyline (as hydrochloride) 10 mg and 25 mg Tablets

1 Nortriptyline NRIM 09052013 NEW ZEALAND DATA SHEET Nortriptyline NRIM . Nortriptyline (as hydrochloride) 10 mg and 25 mg Tablets . This product may not be interchangeable with similar products on the New Zealand market

2. QUALITATIVE AND QUANTITATIVE COMPOSITION 3 ...

1. PRODUCT NAME LOSARTAN ACTAVIS (Losartan Potassium 12.5mg, 25mg, 50mg and 100mg Tablets) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains: 12.5 mg losartan potassium 25 mg losartan potassium 50 mg losartan potassium 100mg losartan potassium . For the full list of excipients, see section 6.1. 3. …

  Product, Name, Qualitative, Losartan, Product name losartan

Breast Pathway Group Paclitaxel weekly in Advanced Breast ...

Breast Pathway Group – Paclitaxel weekly in Advanced Breast Cancer Version: 1.0 Supersedes: all other versions Approved by LCA Breast Pathway Chemotherapy Lead: Mark Harries November 2014

  Weekly, Paclitaxel, Paclitaxel weekly

HIGHLIGHTS OF PRESCRIBING INFORMATION • Initial doseof …

4 2.3 Important Dosing Considerations If the patient has missed a dose of Herceptin by one week or less, then the usual maintenance dose (weekly schedule: 2 mg/kg; three-weekly schedule: 6 mg/kg) should be administered as soon as

  Information, Prescribing, Prescribing information, Weekly

Page 1 of 4 Paclitaxel Albumin (Abraxane®) and Gemcitabine ...

Repeat FBC, if recovered to above these levels, resume treatment at full dose. Consider dose reduction for >1 delay.

  Paclitaxel, Albumin, 1 of 4 paclitaxel albumin

Chemotherapy Sequencing Guide – For therapies given on …

Bevacizumab Bleomycin Carboplatin Cisplatin Cyclophosphamide Cytarabine Dacarbazine Docetaxel Doxorubicin Epirubicin Etoposide Fludarabine Fluorouracil Gemcitabine ...

  Guide, Sequencing, Therapies, Chemotherapy, Chemotherapy sequencing guide for therapies

Clinical trials of Herceptin (trastuzumab)

Clinical trials of Herceptin1 (trastuzumab) J. Baselga* Department of Medical Oncology, Hospital General Universitari Vall d’Hebron, Psg. Vall d’Hebron, 119-129, E-08035 Barcelona, Spain

  Clinical, Trail, Clinical trials of